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Abstract
Porcine parvovirus (PPV) is a DNA virus that causes reproductive failure in gilts and sows, resulting in embryonic
and fetal losses worldwide. Epitope mapping of PPV is important for developing new vaccines. In this study, we
used spot synthesis analysis for epitope mapping of the capsid proteins of PPV (NADL-2 strain) and correlated the
findings with predictive data from immunoinformatics. The virus was exposed to three conditions prior to
inoculation in pigs: native (untreated), high hydrostatic pressure (350 MPa for 1 h) at room temperature and high
hydrostatic pressure (350 MPa for 1 h) at − 18 °C, and was compared with a commercial vaccine produced using
inactivated PPV. The screening of serum samples detected 44 positive spots corresponding to 20 antigenic sites.
Each type of inoculated antigen elicited a distinct epitope set. In silico prediction located linear and discontinuous
epitopes in B cells that coincided with several epitopes detected in spot synthesis of sera from pigs that received
different preparations of inoculum. The conditions tested elicited antibodies against the VP1/VP2 antigen that
differed in relation to the response time and the profile of structurally available regions that were recognized.
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Introduction
Porcine parvovirus (PPV), or Ungulate Protoparvovirus 1
as proposed by Cotmore et al. [1], is a 25-nm diameter,
non-enveloped icosahedral virus that contains ~ 5 kb of
negative sense, single-strand DNA (ssDNA) with two large
open reading frames (ORFs) in its genome. ORF1 codes
for the nonstructural proteins NS1, NS2 and NS3, and
ORF2 codes for the structural proteins VP1, VP2 and VP3
[2]. VP1 and VP2 capsid proteins are the result of an alter-
native splicing of the same gene and VP3 is formed by
proteolytic cleavage of VP2. These structural proteins are
responsible for the immunogenic properties of PPV [3].
PPV infects pregnant gilts and sows, causing reproductive
failure characterized by embryonic and fetal death, mum-
mification and stillbirths, with delayed return to oestrus
[4]. The resulting reduction in reproductive capacity can
significantly decrease pork production [5].
PPV is prevalent in the pig population and highly
stable in the environment, which make it difficult to
establish and keep breeding populations free of the virus.
For this reason, it is important to maintain herd immun-
ity against PPV [4]. The most widely used approach for
maintaining immunity is regular vaccination of breeding
females. Two main strains of PPV, NADL-2 (non-patho-
genic) and Kresse (pathogenic), have been identified
based on pathogenicity, although sequence analysis of
recent isolates suggests active evolution of PPV [6]. The
vaccines commercially available since the 1980s are
based on a chemically-inactivated NADL-2 strain.
The development of vaccines is important for control-
ling diseases such as reproductive failure caused by PPV.
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In this context, essential considerations should include
viral diversity, protective immunity and population cover-
age as key factors, all of which pose special challenges to
this ever-expanding field [7, 8]. One well-known approach
in vaccine production is the use of inactivated viral prepa-
rations [9, 10]. In recent years, the use of high hydrostatic
pressure (HHP) has become an increasingly popular
non-thermal method of inactivation [11–13]. This ap-
proach has been successfully used to inactivate several vi-
ruses and represents a promising alternative to vaccine
development [14]. A major advantage of viral-inactivation
by HHP is that key immunological sites are retained in-
tact, thereby enhancing the usefulness of the inactivated
virus in vaccine development. HHP also induces a potent
and directed immune response without introducing new
chemicals to the process. In this study, we used a combin-
ation of in silico and in vivo approaches to examine the
immune responses to different HHP-PPV formulations
that were then compared with a commercial vaccine pro-
duced using chemically-inactivated virus.
Material and methods
Virus preparation
The NADL-2 strain of PPV was cultured in SK6 cells as
previously described [15]. Supernatants of cell cultures
were separated and purified by CaCl2 precipitation
followed by gradient ultracentrifugation [16]. Fractions
with hemagglutinating activity were dialyzed for 16 h at
4 °C against a Tris-EDTA buffer, pH 8.0 [17]. The virus
was titrated in SK-6 cells by serial dilutions in 96
well-plates and the cells were then screened for a cyto-
pathic effect at 72 h post-infection. The test was consid-
ered positive when cytopathic effects were observed in >
75% of the cells. Samples containing 1 × 104.5 TCID50/
mL were aliquoted and subjected to HHP. Vaccine ali-
quots and viral preparations were normalized to avoid
an antigen-concentration effect [18].
Briefly, virus aliquots were subjected to two treatments:
one at 300MPa for 1 h at 25 °C and another at 300
MPa at − 18 °C, both immersed in 0.1 M Tris-HCl,
pH 7.4. The equipment used to treat the samples con-
sisted of a pressure generator device (model HP ISS)
coupled to a pressure cell, as previously described
[19]. The freezing point (i.e., − 19 °C) for these condi-
tions was determined to be lower in previous studies
by our group [20].
Pig immunization and sample collection
This experimental study was done at the Embrapa
(Brazilian Agricultural Research Corporation) Swine and
Poultry Station, located in the southern Brazilian state of
Santa Catarina. All the experimental protocols involving
animals were approved by an institutional Animal Care
and Use Committee (Embrapa, protocol no. 003/2009).
Ten 21-day-old specific-pathogen-free (SPF) male pigs
from a terminal cross of Landrace and Large White line-
ages were divided into five groups of two pigs each: N
(native PPV), P (PPV treated with 350MPa at 25 °C),
P-18 (PPV treated with 350MPa at − 18 °C), V (commer-
cial inactivated PPV vaccine, Farrow sure B, Pfizer) and
NC (negative control). Pigs were vaccinated intramuscu-
larly on day 0 (D0), D14, D28 and D38 according to each
HHP protocol, as previously described [21]. Pigs in the
NC group received only saline solution. On D51, all pigs
were challenged intranasally with a reference strain of
PPV NADL-2 [22]. Serum samples were collected prior
to each vaccination or challenge (D0, D14, D28, D38
and D51), as well as on D58, D65 and D72.
Spot synthesis
The peptides were synthesized based on the amino acid
sequence of VP1 from PPV NADL-2 strain (GenBank,
accession no. NC 001718) with 12 overlapping peptides
and an offset of four peptides. The membrane used for
spot synthesis was prepared with Fmoc (9-flurorenyl-
methoxycarbonyl) chemistry [23, 24] on a PEG-derived
cellulose membrane with the addition of a C-terminal
anchor of β-Ala residues and hexadecapeptides at the
N-terminal. All serum samples from D0, D28, D58 and
D72 (representing, respectively, the basal serum condi-
tion prior to any intervention, the antibody response
against the vaccine, the challenge with the reference
strain and 21 days after the challenge) were screened for
antibodies. An anti-swine IgG-Fc secondary antibody
conjugated with alkaline phosphatase (Jackson Immu-
noResearch Europe Ltd.) was used to assess epitope
recognition in the peptide arrays and downstream proce-
dures were done as previously described [24]. The mem-
brane was subsequently scanned at 1200 d.p.i. with a
Print Scan Copier (HP Photosmart) and the software
package “Totallab Quant-Array Analysis” was used to
quantify the spots based on the intensity of the reaction
relative to the background intensity. Signal below the
arbitrary threshold of 0.2 were considered negative.
Conformational epitope prediction
The complete primary sequence of the capsid protein of
the reference strain was obtained from the UniProt Know-
ledge Base (UniProtKB) database (accession no. P18546)
and used for downstream applications. The physicochemi-
cal properties of amino acids were considered and
assessed using the Karplus and Schulz flexibility scale [25].
The antigenicity of the protein was inferred with the
Kolaskar and Tongaonkar scale, a semi-empirical method
to predict antigenicity from the physicochemical proper-
ties of amino acids in protein sequences [26, 27]. The
hydrophobic properties of the sequence were predicted
with the Parker hydrophilicity scale [28]. The full length
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VP1 protein has not yet been crystallized. Therefore, to
obtain a better understanding of the epitope mapping
results we produced models for the first 174 amino acids
encompassing both the PLA2 domain and the nuclear
localization signal, as well as the remaining residues,
known to be buried in the PPV structure under
physiological pH, but exposed in the early stages of
productive infections. The phospholipase A2 (PLA2),
nuclear localization signal and connecting regions of
the VP1 protein were modeled using the software
I-TASSER (v. 5.1) [29] and the output evaluated in the
webserver MolProbity [30]. All models were energy
minimized in GROMACS and protonation states were
adjusted to pH 5.0 (to mimic those for endosome
fusion states and PLA2 exposure). B cell epitope pre-
dictions were done using the crystal structure (PDB
entry:1K3V) and the homology model generated for
the VP1 complex with the softwares Bepro [31], Disco-
tope2 [32] and Epitopia [33].
Molecular dynamics
The crystallized structure of the VP2 protein (PDB code
1k3v) was downloaded from the Protein Data Bank and
the coordinates were used to generate the VP1-PPLA
model in the I-TASSER5.1 suite coupled with coordi-
nates for the PPLA structure as the input for the hom-
ology model protocol (option 4). Molecular dynamics
simulations were done with the GROMACS software (v.
2016.3) [34] to evaluate putative structural changes
caused by HHP (350MPa) at 27 °C and − 18 °C relative
to the control conditions nder physiological conditions.
Two systems were devised for the simulation run using
a rombic dodecahedron as the simulation box limited at
10 A from the protein edges. The VP1-PPLA system was
created with 138,811 atoms (11,221 atoms for the
VP1-PPLA protein) and 75,857 atoms with 8447 atoms
representing the VP2 solvated protein. The AMBER99SB
force field was applied and the TIP3P explicit water
model were selected for the nvt and npt equilibration
protocols. The electrostatic interactions were calculated
by using the particle mesh Ewald (PME) method for the
van der Waals interactions and the electrostatic interac-
tions in the real space of the PME method. Energy
minimization steps were conducted in vacuum using the
steepest descent integrator until convergence followed
by solvation and ion equilibration of the systems to prepare
the systems for the NVT and NPT equilibration steps. To
simulate the experimental conditions the equilibration sys-
tems were normalized to 300 K at atmospheric pressure
followed by modifications in the NVT and NPT mdp op-
tions to mimic the desired HHP conditions of 350MPa at
27 °C and 350MPa at − 18 °C. After the systems were
equilibrated production runs for each condition were con-
ducted for 20 ns and the outputs analyzed for structural
parameters such as root mean square deviations
(RMSD), root mean square fluctuations (RMSF), radius
of gyration, secondary structure fluctuations and also
for the complete system, such as pressure, temperature
and energy variations. Plots were generated with the
Grace software package (http://plasma-gate.weizmann.
ac.il/Grace/) and trajectory analyses were done using
the VMD package as well as the built-in analysis pack-
ages present in GROMACS [35].
Results
Epitope mapping
A schematic representation of the membrane is depicted
in Fig. 1a, with the positive spots highlighted in Fig. 1b
and c, portraying the detailed conditions for each posi-
tive result (different HHP treatments and serum sam-
pling intervals). None of the serum samples collected at
D0 bound any polyclonal antibodies. Negative control
pigs (group NC) showed positivity only after PPV inocu-
lation (D58), which reflected sites usually activated when
natural PPV infection occurs (sites 13 and 16 that cor-
respond to amino acid residues 493–512 and 585–608,
respectively) (Figs. 1c & 2a).
The data for each experimental condition and time
point are shown as pairs of graphs in Fig. 2. The
spot intensity is shown and was considered positive
in Fig. 2a, c, e, f and i; the corresponding location
was mapped onto the crystal structure of PPV VP2, with
color coding according to the time point (Fig. 2b, d, f, h
and j). There was a predominance of red and yellow re-
gions in several conditions, indicating that the initial posi-
tivity in a given region frequently did not persist after
challenge. In addition, spots that were positive after chal-
lenge were not preceded by positive epitope mapping in
initial inoculations.
In comparison with the negative control the epitope
mapping for the PLA2 domain in the VP1 sequence was
pronounced in all treatments (Fig. 2a, c, e, g - Spots: A5
to A15 amino acids: 17 to 72). A similar pattern of im-
mune response directed against these regions was ob-
served in all treatments, differing mainly when the
response was first detected. The PLA2 domain elicited a
two-fold response when the P-18 treatment was used,
suggesting that the treatment provided means for this re-
gion to be favored regarding antibody production at earl-
ier stages if compared with the other treatments and
positive control. The region formed by residues 61 to 124,
associated with the connecting region between the PLA2
domain and the VP1 capsomer, produced higher and sus-
tained antibody binding over the course of the experi-
ments only for the P-18 treatment; the latter was detected
in all data points after the first challenge, in contrast with
the N, P, and V treatments for which the region began to
be recognized only after D72 (Fig. 2a, c, e, g, Spots: A17 to
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Fig. 1 Epitope mapping results for the different conditions of pig inoculations. a Membrane spot array with each hexadecapeptide showing the
VP1 amino acid position in each cell. The highlighted spots (purple, n = 44) correspond to positivity in at least one of the experimental
conditions. b An explanatory framework for panel c. c Detailed data for the spots highlighted in a, showing the corresponding positivity for the
experimental conditions and sample collection days (D0, D28, D58 and/or D72). Consecutive positive spots were denominated “sites” (n = 20)
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B3, amino acids: 65 to 124). Overall, the low temperature
and high pressure treatment induced prolonged antibody
production with earlier availability for the first 174 resi-
dues spotted.
Pigs from group N showed no significant reaction on
D28, except for sites 7 and 13 that correspond to amino
acid residues 197–216 and 493–516, respectively. When
samples from D58 (representing the immune response
Fig. 2 Intensity of the colorimetric output of the antibody-bound alkaline phosphatase reactions (panels a (NC), c (N), e (V), g (P) and i (P-18))
and a structural representation of each mapped region on the crystal structure of VP2 for each condition (panels b (NC), d (N), f (V), h (P) and j
(P-18)). The signal intensity of the positive spots is shown in Fig. 1c, based on sample collection days D0, D28, D58 and D72, and was used to
reconstruct epitope maps of PPV in graphs for the whole protein. The X-axis corresponds to the spot position (in agreement with Fig. 1) and four
results are shown per spot. The Y-axis shows the relative intensity for each spot. The data was normalized for each experimental condition and a
threshold was set at 40% of the maximum intensity. The models on the right show the crystallographic structure of VP2 protein (PDB entry 1k3v)
with positivity indicated as yellow for D28 and/or D58, red for D72, and orange for positivity in both D28 and/or D58 and D72
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after PPV challenge) were analyzed, additional positivity
occurred at sites 1 (aa 1–20) and 19 (aa 685–700). When
antibodies obtained after the challenge with active virus
were mapped against the membrane (D72), numerous
additional epitopes were detected, namely, 2 (aa 45–60),
3 (aa 57–72), 4 (aa 65–96), 6 (aa 125–140; 133–152), 12
(aa 453–476), 14 (aa 529–544), 17 (aa 637–652) and 18
(665–684). The region initially detected at site 7 (aa
201–216) on D28 and D58 was not detected in the last
sample (D72).
For group V, immunoreactivity was observed only
on D58. In this case, PPV antibodies were detected at
more sites than with the native form of the virus. Sites
3 (aa 57–72), 4 (aa 65–80; 73–100), 6 (aa 133–152), 12
(aa 453–472), 15 (aa 565–580), 18 (aa 665–684) and
20 (aa 713–729) had bound antibodies, in contrast to
group N for which no signal was found in the same re-
gions at D58. Epitope mapping after the viral chal-
lenge (D72) showed higher agreement with the map of
group N, but distinct regions were also found for sites
1 (aa 9–24), 6 (aa 121–136; 129–144), 7 (aa 205–220),
8 (aa 217–232), 9 (aa 229–244) and 10 (aa 397–412).
In general, a higher number of sites was induced and
recognized in group P than in group N, but this number
was lower than in group V. Sites 1, 4, 6, 13 and 18 pre-
sented in group P were also found on D28 and D58 in
group V, and sites 1 and 13 were also detected in group
N. At the last sample collected (D72), the native form
(N) showed more antigenic sites compared with groups
P and V (Table 1S and Fig. 1c). Site 1 showed the highest
frequency of positive spots on D28, D58 and D72 in
groups N, P and V (Table 1S and Fig. 1c).
In group P-18, there was an increase in the number of
positive spots (Fig. 1c). This situation was similar to
group N, but the mapped response was higher when
P-18 was compared to groups P, V and NC. Group P-18
pigs showed positive antibody responses earlier than the
other treatments and included sites 1, 3, 4, 6, 12, 18, 19
and 20 (Fig. 1c). This group was the only in which
sites 5 (aa 101–116; 109–124), 7 (aa 209–224) and 11
(aa 429–444) were activated on D72.
Bioinformatic analysis
A combination of immunoinformatic tools was used to
understand the molecular recognition of the VP1-VP2
capsid proteins based on the epitope mapping results
described above. By using the reference sequence of
NADL-2 strain, in silico predictions identified sites with
a high probability of being antigens. Since this method
does not evaluate tertiary structures and is based on a
sliding window to produce propensity scores, we identi-
fied six regions out of the 24 predictions that overlapped
with the results for group N.
Based on properties such as solvent-accessible surface
area (SASA) and hydropathy predictions these regions
were found to be exposed and hydrophilic, thus provid-
ing basic information for the experimental detection of
such regions as epitopes in group N. In view of the con-
formational epitope predictions and conservative set-
tings used, few regions returned positive conformational
epitope predictions. However, by balancing for sensitivity
and specificity the algorithms were able to detect puta-
tive epitopes on the 1k3v reference structure (public
data), albeit in distinct regions when compared with our
epitope mapping of the untreated virus.
Currently molecular dynamics simulations of viral pro-
teins are common ground in viroinformatics, on the
other hand using this tool to investigate HHP effects in
combination with epitope mapping strategies is gaining
momentum. Precious insights can be harnessed from
molecular dynamics simulations and the correlation with
our experimental desing and results added value to the
in vitro results. The method is powerful enough to evalu-
ate structural perturbations in a given system under pres-
sure and it has been extensively used before to dissect the
effects of HHP in proteins. As expected from previous re-
ports our results show small deviations in RMSD fluctua-
tions with decreased positional movements as a function
of the conditions applied to the system in silico. Molecular
dynamics analysis of the problem investigated the be-
havior of the VP1-PPLA (Additional file 1: Figure S1 &
Additional file 3: Figure S3) and VP2 (Additional file 2:
Figure S2 & Additional file 4: Figure S4) under normal
conditions and under the conditions of groups P and
P-18. A 20 ns molecular dynamics simulation allowed
comparison of the radius of gyration (Rg), an indicator
of protein compactness, with the group N simulation
and revealed an overall decrease of 0.42% in Rg for
group P vs. group N (2.85 nm vs. 2.838 nm) and a 0.87%
decrease for the P-18 simulation compared to group N
(2.85 nm vs. 2.826 nm) (Additional file 1: Figure S1 &
Additional file 2: Figure S2), suggesting that the simulation
produced a more constrained protein. The total energy
of the HHP simulation increased 0.83% against group
N (− 2.385 × 106 cal versus − 2.405 × 106 cal) whereas
that for group P-18 increased 9.85% (− 2.385 × 106 cal
versus − 2.635 × 106 cal) (Additional file 1: Figure S1).
Conversely, a marked decrease in total volume was re-
corded during the group P and P-18 simulations com-
pared with group N, which fluctuated around 1835 nm3
vs. 1680 nm3 (P) and 1655 nm3 (P-18), suggesting that
the simulation was successful in creating the desired
pressure and temperature for the experiment (Add-
itional file 1: Figure S1 & Additional file 2: Figure S2).
The RMS fluctuation after the production run revealed
the baseline values for the native protein atom fluctua-
tions in accordance with the predicted flexible regions of
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the protein and provided a basis for comparison with
the group P and P-18 simulations. As a result, the P
simulation narrowed the amplitude variation per atom,
thereby collapsing the flexible regions and limiting the
overall variation to 0.01 nm. Furthermore, the P-18
simulation produced a more rigid configuration with no
fluctuations > 0.05 nm on all atoms, in agreement with
the other parameters (total volume, total energy and
Rg). Interestingly, the area per residue over the trajec-
tory increased substantially in the group P and P-18
simulations (Additional file 3: Figure S3 & Additional
file 4: Figure S4). Moreover, the number of contacts
maintained between residues decreased substantially when
groups P and P-18 were compared with control group N
(Additional file 3: Figure S3 & Additional file 4: Figure S4).
Discussion
Epitope mapping strategies have been extensively applied
to key pathogens and the results provided by this ap-
proach have important applications in public health, as
well as in animal safety and welfare [36–40]. There are
ongoing efforts to identify the key epitopes on the
VP1-VP2 capsid proteins of PPV through distinct strat-
egies for mapping. A study in which Pepscan was used
to synthesize 24 different peptides directed towards anti-
genic sites detected nine such sites and posited that
those found in the N-terminal region were neutralizing
epitopes [41]. Xie et al. [3] confirmed these findings by
using a monoclonal antibody (C4) against VP1 of PPV
to screen a 12-mer phage peptide library. These authors
identified a mimotope corresponding to the N-terminal
immuno-dominant region that protected mice against
the virus. In the present study, we mapped 20 “antigenic
sites” corresponding to 44 positive spots based on a
combination of experimental conditions that consisted
to vaccination/challenge settings. Distinct patterns of
epitope positivity were observed, depending on the ex-
perimental conditions to which the antigen was sub-
jected and on whether the vaccination or challenge
phase was being assessed (Fig. 2a-j).
To our knowledge, spot synthesis methodology has
not previously been applied to PPV in this manner and
the results obtained here provide a comprehensive land-
scape of the immunological profile of the VP1-VP2 com-
plex by slicing the protein into overlapping oligopeptides
bound to a nitrocellulose membrane. The spot results
are quantifiable and give satisfactory parallel compari-
sons with ELISA findings, such as for determining pro-
tein concentration [42]; the methodology is reproducible
and has been used for quality control [43].
The PLA2 domain is responsible for crucial steps in
the PPV infection cycle by facilitating the release of the
virus near the nucleus after successful endosome forma-
tion and prior to the activation of nuclear localization
signaling. Numerous studies since the 1980s have inves-
tigated the latter event following the demonstration that
microinjections of antibodies can interfere with intracel-
lular antigens [44]. The inhibition of antigen function by
the binding of antibodies to their antigen within endo-
somes is dependent upon factors such as exposure, iden-
tity and, primarily, pH. Important advances have been
made using genetic engineered antibodies to sustain
binding at lower pH [45]. Identification of the IgGs that
successfully bind to key viral proteins or functional do-
mains (as in the present case) is of utmost importance
in tackling infections early on. The results described
here indicate that the native conformation of the virus
elicited an immune response against the PLA2 target,
but only in later stages of antibody production, whereas
pressure and the combination of low temperature and
pressure evoked an exuberant response that was signifi-
cant at all sampling intervals in the P-18 experiment.
By combining molecular dynamics with epitope map-
ping, it was possible to investigate the putative alterations
that HHP may have induced in protein conformation and
in the solvent-accessible surface area. The native form of
the protein, used here as a positive control, provided the
epitope landscape to which pigs responded at three sam-
pling times. Initially, group N showed a strong antibody
response for spots B25 (aa 197–212) and C1 (aa 201–216)
at sampling times D28 and D58. These spots correspond
to the N-terminal region of VP2, information that is also
present in the crystal structure of VP2. Epitopes located in
the VP2 capsid protein of PPV are important for generat-
ing neutralizing antibodies against this virus, with a high
potential to activate B cells. These studies indicate that the
N-terminal of VP2 is a strong candidate for B cell epitopes
and should be included in vaccines [46, 47]. Antibodies
that bound to a region composed of amino acids 497–516
were seen soon after the second inoculation and the titers
(inferred from the intensity of the phosphatase reactions)
were maintained throughout the experiment. The immu-
nodominant regions in VP2 belong to the loops and other
regions in the N- and C-terminals [41, 46, 47]. As shown
in Fig. 2b, d, f, h and j, the loop regions marked by Pro500
and Val175 occurred in epitopes present in the five groups,
with an alternation of these regions in three intervals of
serum collection.
Although the capsid proteins were deemed to be
under near-neutral selection, a few key amino acids were
found to be variable (aa 215, 228, 383, 414, 419 and
436), with most of them located in surface loops [6, 48].
Zeeuw et al. [49] have previously shown that the strain
switch from avirulent (143a) to virulent (27a) might de-
pend directly on mutations of VP2 residues 378 and 383.
As expected, surface amino acids in the VP2 configur-
ation are hydrophilic and contain most of the mutations
identified by Ren et al. [50], who also found this protein
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to be under negative selection. Antibody responses
against overlapping peptides of VP1 were not detected
until late time points, precisely after the viral challenge,
when amino acids 5 through 96 produced significant
binding, thereby reinforcing previous findings regarding
the N-terminal immunogenicity of PPV VP1 [3].
In contrast to these results, vaccine epitope mapping
elicited marked responses against the N-terminal region
of VP1 after D38, with moderate binding to the previ-
ously mentioned VP2 regions. HHP elicited responses
like those of the vaccine in the VP1 N-terminal region,
as well as for the VP2 variable regions mentioned before
on the fourth inoculation, prior to the challenge with PPV.
In our study, amino acid residues (45, 217–219 and 556)
corresponding to the mapped epitopes included some of
the sites reported by Streck et al [51] The substitution of
amino acid residues at sites located mainly on the surface
of PPV is important not only for understanding the evolu-
tionary mechanism of adaptive response to the host, but
also for identifying possible strategies to produce more ef-
fective vaccines against PPV.
HHP treatment of PPV at 25 °C and − 18 °C did not
suppress antigenicity but elicited the appearance of
several other epitopes through the exposure of parts of
the capsid. Although HHP did not directly affect the ter-
tiary structure of the proteins, the exposure of different
parts of the proteins, including hydrophobic regions, in
response to these conditions could explain the appear-
ance of new epitopes [52]. A direct comparison of the
secondary structures of the VP2 crystal structure ob-
tained after a 20 ns molecular dynamics simulation of
the experimental conditions also showed small alter-
ations to the original configuration (SF 2ary), mostly
from switches between flexible regions (the most fre-
quent interconversions found were from coil to bend,
turn to3-helix and alpha-helix to turn to 3-helix). Con-
versely, HPP and low temperature HPP produced more
stable secondary structures compared to the simulation
with no pressure or temperature constraints. HHP and low
temperature HHP simulations displayed small fluctuations
during the production run and only the N-terminal region
of the VP2 1K3V structure showed changes in configur-
ation (amino acids 40–90). Compared with the molecular
dynamics of native VP2, the HHP simulation tended to
produce fixed turns where interconversion between bends
and turns were recorded (amino acids 45–55) whereas low
temperature HHP fixed this region in a 3-helix configur-
ation. The region from amino acids 75–85 fluctuated
among alpha-helix/turn/3-helix configurations in the na-
tive simulation but the region was then fixed as an
alpha-helical structure in the HHP run and varied between
turns and bends in the low temperature HHP run. The in-
teractions mounted by the protein-solvent system at HHP
are more favorable and due to small deformations in the
internal bonds the protein-protein interaction energies are
also increased (total energy graphs). The H-bond network
is also favored by HHP, as previously reported for SOD,
lysozyme and BPTI, the results for the capsid proteins
H-bond network were increased during the simulation and
were significant when compared against the N state. More
studies are necessary to evaluate if possible correlations
can be produced from MD simulations and putative im-
munological responses. An important limitation of our
study is the simulation of single proteins in water, it is of
particular interest full-atom simulations of complete viral
capsids in water subjected to HHP and cold denaturation
processes to expand in this field as computational power
becomes available.
Previous reports have identified important structural
changes in globular proteins after exposure to HHP, with
increased disordered structures and turns, as well as de-
creased β-sheets and α-helices [13]. These findings suggest
that the effect of pressure on kinetics arises from a larger
positive activation volume for folding than for unfolding;
this in turn leads to a significant slowing down of the
folding rate with increasing pressure. For viral capsids
under HHP, D’Andrea et al [53] noted that the treatment
enhanced the viricidal effect on hepatitis A virus, a
non-enveloped virus, indicating that the efficacy of treat-
ment depends on capsid conformation. These authors
suggested a correlation between mature and immature
capsids, with the accessibility of the immunodominant site
near the five-fold axis possibly explaining the susceptibility
of the virus to inactivation by HPP [53].
Current methods of vaccine production make use of haz-
ardous chemicals that may pose a risk to vaccine recipients.
The efficacy of HHP for inactivating a variety of foodborne
pathogenic microorganisms is well-established, and some
of these microorganisms have been demonstrated to retain
immunogenic properties, a finding which suggests that
HHP may have an application in vaccine development. In-
deed, pressure can result in virus inactivation while preserv-
ing immunogenic properties [11, 12, 14, 21]. The forces
governing viral assembly and disassembly rely on both the
microenvironment and the protein-protein interaction net-
work produced by their genetic codes [54]. The contribu-
tions from studies on the dynamics of capsid autoassembly
in vitro and in silico have provided interesting insights into
the behavior of such ensembles. As illustrated by Silva et al.
[14] and tested in silico in a number of conditions [55–57],
the use of HHP methods alters the distribution of forces in
the viral capsid to promote an energy compliant structure;
this treatment results in a tangible output as epitopes re-
vealed by this method are of great interest for both diagnos-
tics and basic research.
More studies are necessary to understand the influence
of the selective pressures on structural conformations and
the correlation of the HHP method in revealing different
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epitopes. Recent work by Letko et al. [58] addressed fun-
damental questions on the subject by conducting serial
passages of the virus while selecting for a new receptor
adaptation expressed on the target cell; this approach
allowed the identification of key structural aspects in the
viral code that permitted receptor adaptation to a new re-
ceptor. In silico simulation methods provide good models
for processes on this scale and allow important compari-
sons with experimental approaches, with all-atom simula-
tions of full virus capsids becoming computationally
feasible for most laboratories [59]. The latter authors also
suggested that a dynamic h-bond network could poten-
tially have a role in ion selectivity within the capsid. The
effect of HHP on protein structure has been increasingly
studied in silico as computational power and resources be-
come increasingly available; such analyses have substan-
tially advanced our understanding of the influence of each
experimental condition on its target. Protein compressibil-
ity has been tested in silico in several configurations. Voi-
chita [60] reported the effect of pressure on globular
proteins by measuring the variations in protein total vol-
ume and the volume variation per residue after picosec-
ond exposures. The findings suggested that protein
volume was significantly compressed during HHP experi-
ments in silico and that this effect was mostly due to the
difference between SASA and the VdW radii. Second-
ary structures also contributed to the results obtained,
with the compressibility of α-helices being inferior to
that of β-sheets. In contrast, Vahidi et al. [61] found
that in silico HHP failed to modify secondary struc-
tures such as β-barrels, thus agreeing with previous
findings for loops and helical structures.
Inactivated or attenuated strains of PPV for vaccine
production may be useful for controlling this virus in
pigs. In this context, epitope mapping of immunogenic
proteins of PPV is crucial for assessing the immune
recognition of such viral preparations with a potential
use in vaccine preparation, as shown here for the
immunization of pigs. In the present case, the combin-
ation of HHP and epitope mapping provided a broader,
more refined perspective of the epitope landscape stim-
ulated by each preparation. This information could po-
tentially be used to track HHP-vaccinated pig herds as
a first scenario, or, conversely, be used as a combined
alternative to cover the immune response against the
virus. Taken together, our findings provide detailed
insight into the immune system of pigs when the ani-
mals are stimulated with the same molecular configur-
ation of an antigen, the structure of which can be
altered by pressure and temperature. These data also
improve our understanding of site-directed antibody
production over time and of the putative immuno-
logical dynamics of antibody selection before and after
a challenge with antigen.
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Additional file 1: Figure S1. Results for molecular dynamics production
runs: First line: results for 20 ns of a negative control production run for
VP1-PPLA model. A – Volume, B – Temperature, C – Pressure. Second line:
results for 20 ns of a production run for VP1-PPLA model simulated under
pressure and low temperature. D – Volume, E – Temperature, F – Pressure.
Third line: results for 20 ns of a production run for VP1-PPLA model simulated
under pressure: G – Volume, H – Temperature, I – Pressure. (TIFF 4251 kb)
Additional file 2: Figure S2. Results for molecular dynamics production
runs: First line: results for 20 ns of a negative control production run for
1k3v (VP2 crystal). A – Volume, B – Temperature, C – Pressure. Second
line: results for 20 ns of a production run for 1k3v simulated under
pressure and low temperature. D – Volume, E – Temperature, F –
Pressure. Third line: results for 20 ns of a production run for 1k3v
simulated under pressure: G – Volume, H – Temperature, I – Pressure.
(TIFF 4032 kb)
Additional file 3: Figure S3. Results for molecular dynamics production
runs: First line: results for 20 ns of a negative control production run for
VP1-PPLA model (A,B – N; C,D – P; E,F – P-18). A – RMSF per residue, B –
Solvent Accessible Surface Area per residue, Second line: results for 20 ns
of a production run for VP1-PPLA model simulated under pressure and
low temperature. C – RMSF per residue; D – Solvent Accessible Surface
Area per residue. Third line: results for 20 ns of a production run for VP1-
PPLA model simulated under pressure: E – RMSF per residue, F – Solvent
Accessible Surface Area per residue. (TIFF 1123 kb)
Additional file 4: Figure S4. Results for molecular dynamics production
runs: First line: results for 20 ns of a negative control production run for
1k3v (VP2 crystal) (A,B – N; C,D – P; E,F – P-18). A – RMSF per residue, B –
Solvent Accessible Surface Area per residue, Second line: results for 20 ns
of a production run for 1k3v (VP2 crystal) simulated under pressure and
low temperature. C – RMSF per residue; D – Solvent Accessible Surface
Area per residue. Third line: results for 20 ns of a production run for 1k3v
(VP2 crystal) simulated under pressure: E – RMSF per residue, F – Solvent
Accessible Surface Area per residue. (TIFF 1121 kb)
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